Kashi Javaherian
6Patents
2h-index
12Co-inventors
48Inventor score
Filing activity: Feb 2, 1996 → Apr 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6444792B1 | CTLA4-C&ggr;4 fusion proteins | Chemistry; Metallurgy | 104 | Expired |
| US6750334B1 | CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor | Chemistry; Metallurgy | 46 | Expired |
| US7524811B2 | Anti-angiogenic peptides from the N-terminus of endostatin | Human Necessities | 2 | Expired |
| US7645735B2 | Anti-angiogenic peptides for treating or preventing endometriosis | Chemistry; Metallurgy | 1 | Expired |
| US11845784B2 | Means and methods for the treatment of angiogenesis-, fibrosis- and cancer-related diseases with protein oligomers comprising NC-1-Fc | Chemistry; Metallurgy | 0 | Active |
| US11548934B2 | Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.